182 related articles for article (PubMed ID: 15085682)
1. The Rhode Island meningitis vaccine experience--mass vaccination campaigns, politics and health policy.
Nolan P
Med Health R I; 2004 Mar; 87(3):65-7. PubMed ID: 15085682
[No Abstract] [Full Text] [Related]
2. The Rhode Island adult vaccination experience 1995-2003: public health, marketplace values, and lessons learned about the integrity of medicine as a profession.
Fine M
Med Health R I; 2004 Mar; 87(3):75-6. PubMed ID: 15085685
[No Abstract] [Full Text] [Related]
3. The Meningitis Vaccine Project.
LaForce FM; Konde K; Viviani S; Préziosi MP
Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
[TBL] [Abstract][Full Text] [Related]
4. Infectious disease. An ill wind, bringing meningitis.
Roberts L
Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588
[No Abstract] [Full Text] [Related]
5. Infectious disease. Hitting early, epidemic meningitis ravages Nigeria and Niger.
Roberts L
Science; 2009 Apr; 324(5923):20-1. PubMed ID: 19342555
[No Abstract] [Full Text] [Related]
6. Seasonal influenza vaccination coverage among pregnant women in Rhode Island.
Kim H; Raymond P; Paine V; Cain R; Viner-Brown S
Med Health R I; 2009 Oct; 92(10):345-7. PubMed ID: 19911716
[No Abstract] [Full Text] [Related]
7. Meningococcal C vaccines: the Canadian experience.
De Wals P
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
[TBL] [Abstract][Full Text] [Related]
8. The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt.
Nakhla I; Frenck RW; Teleb NA; El Oun S; Sultan Y; Mansour H; Mahoney F
Vaccine; 2005 May; 23(25):3288-93. PubMed ID: 15837234
[TBL] [Abstract][Full Text] [Related]
9. Meningitis. Less vaccine can be more.
Enserink M
Science; 2008 Dec; 322(5907):1449. PubMed ID: 19056945
[No Abstract] [Full Text] [Related]
10. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
Okoko BJ; Idoko OT; Adegbola RA
Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
[TBL] [Abstract][Full Text] [Related]
11. West African meningitis outbreak strains vaccine supplies.
Wakabi W
Lancet; 2009 May; 373(9678):1836. PubMed ID: 19504666
[No Abstract] [Full Text] [Related]
12. [Control of tropical epidemics by vaccination--an update].
Merlin M
Med Trop (Mars); 2007 Aug; 67(4):351-6. PubMed ID: 17926793
[TBL] [Abstract][Full Text] [Related]
13. MeNZB vaccine and epidemic control: when do you stop vaccinating?
Loring BJ; Turner N; Petousis-Harris H
Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
[TBL] [Abstract][Full Text] [Related]
14. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
Chippaux JP; Diallo A; Marra A; Etard JF
Vaccine; 2007 Feb; 25(10):1712-8. PubMed ID: 17240492
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine.
De Wals P
Vaccine; 2009 Sep; 27(42):5730. PubMed ID: 19651172
[No Abstract] [Full Text] [Related]
16. GAO's evaluation of the public health response to the anthrax incidents of 2001, with notes on the Rhode Island experience.
Fulton JP
Med Health R I; 2003 Dec; 86(12):401-2. PubMed ID: 14983545
[No Abstract] [Full Text] [Related]
17. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
[TBL] [Abstract][Full Text] [Related]
18. Active hospital-based surveillance for meningococcal polysaccharide vaccine adverse events after an emergency mass immunization program, Edmonton, Alberta.
Can Commun Dis Rep; 2005 Jun; 31(11):126-30. PubMed ID: 15940838
[No Abstract] [Full Text] [Related]
19. Meningococcal meningitis.
Aguado T; Bertherat E; Djingarey M; Kandolo D; Kieny MP; Kondé K; LaForce FM; Nelson CB; Perea W; Préziosi MP
Nat Rev Microbiol; 2005 Jan; 3(1):10-1. PubMed ID: 15635779
[No Abstract] [Full Text] [Related]
20. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
